D3D patented technology dates back to 2006 (e.g., US Patent 8,384,771, US Patent 9,349,183, US Patent 9,473,766, US Patent 9,980,691, US Patent 10,795,457, US Patent 10,936,090, US Patent 10,942,586, US Patent 11,036,311, US Patent 11,016,579 and US Patent Application 17/339,341).   D3D Technologies worked with Stanford University and has completed a National Science Foundation grant in efforts to revolutionize the way brain aneurysms are diagnosed.

There are almost 500,000 deaths worldwide each year caused by brain aneurysms.

Half of the victims are younger than 50.

Ruptured brain aneurysms are fatal in about 50% of cases.

An estimated 6.5 million people in the US have an unruptured brain aneurysm.

Accurate early diagnosis is critical.

D3D is collaborating with George

Mason University University on a National Institutes of Health grant in efforts to revolutionize breast cancer imaging


According to the American Society of Clinical Oncology, this year

over 250,000 women will be diagnosed with breast cancer and

nearly 40,000 women will die from breast cancer. 


If the breast cancer is confined to the breast, the 5-year survival is 99%.

If the breast cancer has spread to lymph nodes, the 5-year survival is 85%.

If the breast cancer has spread to distant parts of the body, the 5-year survival is 26%.

We aim to help save lives through advanced visualization and early diagnosis.

True 3D imaging. 

We believe that our next generation technology will fundamentally transform diagnostic radiology from the current slice-by-slice approach to a more efficient and more accurate volume-by-volume approach


NSF logo.png